[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman(University of Melbourne), John Violet(Peter MacCallum Cancer Centre), Rodney J. Hicks(Peter MacCallum Cancer Centre), Justin Ferdinandus(Peter MacCallum Cancer Centre), Sue Ping Thang(Peter MacCallum Cancer Centre), Tim Akhurst(Peter MacCallum Cancer Centre), Amir Iravani(Peter MacCallum Cancer Centre), Grace Kong(Peter MacCallum Cancer Centre), Aravind Ravi Kumar(Peter MacCallum Cancer Centre), Declan G. Murphy(Peter MacCallum Cancer Centre), Peter Eu(Peter MacCallum Cancer Centre), Price Jackson(Peter MacCallum Cancer Centre), Mark Scalzo(Peter MacCallum Cancer Centre), Scott Williams(Peter MacCallum Cancer Centre), Shahneen Sandhu(University of Melbourne)
The Lancet Oncology
May 8, 2018
Cited by 1,131

Abstract


Related Papers

No related papers found

Powered by citation graph analysis